Amit Khanal to Myeloablative Agonists
This is a "connection" page, showing publications Amit Khanal has written about Myeloablative Agonists.
Connection Strength
0.146
-
Mahmud N, Khanal A, Taioli S, Koca E, Gaitonde S, Petro B, Sweiss K, Halliday L, Wang X, Patel P, Rondelli D. Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model. PLoS One. 2018; 13(11):e0206980.
Score: 0.146